Indonesia
· Delayed Price · Currency is IDR PT Suparma Tbk Statistics
Total Valuation
PT Suparma Tbk has a market cap or net worth of IDR 952.54 billion. The enterprise value is 1.25 trillion.
| Market Cap | 952.54B |
| Enterprise Value | 1.25T |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | Jun 27, 2024 |
Share Statistics
PT Suparma Tbk has 3.15 billion shares outstanding.
| Shares Outstanding | 3.15B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 5.12% |
| Owned by Institutions (%) | 0.02% |
| Float | 82.81M |
Valuation Ratios
The trailing PE ratio is 8.80.
| PE Ratio | 8.80 |
| Forward PE | n/a |
| PS Ratio | 0.36 |
| PB Ratio | 0.40 |
| P/FCF Ratio | 1.35 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.60, with an EV/FCF ratio of 1.77.
| EV / Earnings | 11.54 |
| EV / Sales | 0.47 |
| EV / EBITDA | 3.60 |
| EV / EBIT | 5.33 |
| EV / FCF | 1.77 |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 27.82.
| Current Ratio | 2.80 |
| Quick Ratio | 1.07 |
| Debt / Equity | 27.82 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | 0.93 |
| Interest Coverage | 6.06 |
Financial Efficiency
Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 4.94%.
| Return on Equity (ROE) | 4.67% |
| Return on Assets (ROA) | 4.39% |
| Return on Capital (ROIC) | 4.94% |
| Revenue Per Employee | 3.37B |
| Profits Per Employee | 138.45M |
| Employee Count | 779 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 2.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -30.73% in the last 52 weeks. The beta is 0.68, so PT Suparma Tbk's price volatility has been lower than the market average.
| Beta (5Y) | 0.68 |
| 52-Week Price Change | -30.73% |
| 50-Day Moving Average | 299.04 |
| 200-Day Moving Average | 325.82 |
| Relative Strength Index (RSI) | 53.33 |
| Average Volume (20 Days) | 450,580 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Suparma Tbk had revenue of IDR 2.63 trillion and earned 108.27 billion in profits. Earnings per share was 34.33.
| Revenue | 2.63T |
| Gross Profit | 443.08B |
| Operating Income | 234.47B |
| Pretax Income | 146.68B |
| Net Income | 108.27B |
| EBITDA | 337.40B |
| EBIT | 234.47B |
| Earnings Per Share (EPS) | 34.33 |
Balance Sheet
The company has 362.36 billion in cash and 658.88 billion in debt, giving a net cash position of -296.52 billion or -94.01 per share.
| Cash & Cash Equivalents | 362.36B |
| Total Debt | 658.88B |
| Net Cash | -296.52B |
| Net Cash Per Share | -94.01 |
| Equity (Book Value) | 2.37T |
| Book Value Per Share | 750.91 |
| Working Capital | 944.53B |
Cash Flow
In the last 12 months, operating cash flow was 748.93 billion and capital expenditures -41.38 billion, giving a free cash flow of 707.54 billion.
| Operating Cash Flow | 748.93B |
| Capital Expenditures | -41.38B |
| Free Cash Flow | 707.54B |
| FCF Per Share | 224.33 |
Margins
Gross margin is 16.83%, with operating and profit margins of 8.91% and 4.11%.
| Gross Margin | 16.83% |
| Operating Margin | 8.91% |
| Pretax Margin | 5.57% |
| Profit Margin | 4.11% |
| EBITDA Margin | 12.82% |
| EBIT Margin | 8.91% |
| FCF Margin | 26.88% |
Dividends & Yields
This stock pays an annual dividend of 12.00, which amounts to a dividend yield of 3.97%.
| Dividend Per Share | 12.00 |
| Dividend Yield | 3.97% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 3.97% |
| Earnings Yield | 11.37% |
| FCF Yield | 74.28% |
Stock Splits
The last stock split was on June 15, 2022. It was a forward split with a ratio of 1.13.
| Last Split Date | Jun 15, 2022 |
| Split Type | Forward |
| Split Ratio | 1.13 |